Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Glutathione S-transferases modulate Cu tolerance in Oryza sativa
This supplement can cause serious side effects
Basic Sci
Why GLP-1 medications have surged in use GLP-1 receptor agonists treat diabetes and now, increasingly, obesity
Research-grade specs Components: CJC-1295 No DAC (GHRH analog) + Ipamorelin (GHSR ligand) 5 MG vial: CJC-1295 5 mg + Ipamorelin 5 mg (10 mg total) 10 MG vial: CJC-1295 10 mg + Ipamorelin 10 mg (20 mg total) CJC-1295 length: 30 amino acids Half-life: ~30 minutes for the No DAC variant, reported in published literature Format: Lyophilized powder, single-vial blend Studied applications GHRH + GHRP receptor-pathway synergy research Pulsatile GH-release studies Comparative research vs the CJC-1295 With DAC variant Receptor-selectivity comparison against each compound alone Quality & trust 99% HPLC purity, third-party tested Mass spectrometry identity confirmation LAL endotoxin testing on every batch Batch-specific Certificate of Analysis included cGMP manufactured in Dallas, Texas (USA) USA same-day shipping (orders before 2pm CT M-F) Free domestic shipping on orders over $200 Storage & handling Store lyophilized vials refrigerated at 28C, protected from light and heat Reconstitute with bacteriostatic water
In addition, variants linked to both GLP1R and GIPR are associated with GLP1 medication-related nausea and vomiting
